These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 8906822)
1. Somatic hypermutation of a lambda 2 transgene under the control of the lambda enhancer or the heavy chain intron enhancer. Klotz EL; Storb U J Immunol; 1996 Nov; 157(10):4458-63. PubMed ID: 8906822 [TBL] [Abstract][Full Text] [Related]
2. Analysis of hypermutation in immunoglobulin heavy chain passenger transgenes. Johnston JM; Ihyer SR; Smith RS; Tai KF; Farmer T; Korsmeyer SJ; Nadon NL; Carroll WL Eur J Immunol; 1996 May; 26(5):1058-62. PubMed ID: 8647167 [TBL] [Abstract][Full Text] [Related]
3. A lambda 3' enhancer drives active and untemplated somatic hypermutation of a lambda 1 transgene. Kong Q; Zhao L; Subbaiah S; Maizels N J Immunol; 1998 Jul; 161(1):294-301. PubMed ID: 9647236 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the role of the 3'alpha heavy chain enhancer [3'alpha E(hs1,2)] in Vh gene somatic hypermutation. Tumas-Brundage KM; Vora KA; Manser T Mol Immunol; 1997 Apr; 34(5):367-78. PubMed ID: 9293770 [TBL] [Abstract][Full Text] [Related]
5. Somatic hypermutation of an artificial test substrate within an Ig kappa transgene. Klotz EL; Hackett J; Storb U J Immunol; 1998 Jul; 161(2):782-90. PubMed ID: 9670955 [TBL] [Abstract][Full Text] [Related]
6. Subtle differences in antibody responses and hypermutation of lambda light chains in mice with a disrupted chi constant region. Zou X; Xian J; Popov AV; Rosewell IR; Müller M; Brüggemann M Eur J Immunol; 1995 Aug; 25(8):2154-62. PubMed ID: 7664778 [TBL] [Abstract][Full Text] [Related]
7. Replacement of Imu-Cmu intron by NeoR gene alters Imu germ-line expression but has no effect on V(D)J recombination. Haddad D; Dougier HL; Laviolette N; Puget N; Khamlichi AA Mol Immunol; 2010 Feb; 47(5):961-71. PubMed ID: 20036775 [TBL] [Abstract][Full Text] [Related]
8. Deletion of a recombined Ig heavy chain transgene in B-lineage cells of transgenic mice. Heinzelmann A; Kumar S; Noggle S; Goedegebuur I; Sauer KM; Rath S; Durdik JM J Immunol; 1998 Jul; 161(2):666-73. PubMed ID: 9670941 [TBL] [Abstract][Full Text] [Related]
9. Regulatory regions 3' of the immunoglobulin heavy chain intronic enhancer differentially affect expression of a heavy chain transgene in resting and activated B cells. Sigurdardottir D; Sohn J; Kass J; Selsing E J Immunol; 1995 Mar; 154(5):2217-25. PubMed ID: 7868895 [TBL] [Abstract][Full Text] [Related]
10. Identification and localization of an enhancer for the human lambda L chain Ig gene complex. Blomberg BB; Rudin CM; Storb U J Immunol; 1991 Oct; 147(7):2354-8. PubMed ID: 1918967 [TBL] [Abstract][Full Text] [Related]
11. A lambda 1 transgene under the control of a heavy chain promoter and enhancer does not undergo somatic hypermutation. Hengstschläger M; Williams M; Maizels N Eur J Immunol; 1994 Jul; 24(7):1649-56. PubMed ID: 8026525 [TBL] [Abstract][Full Text] [Related]
12. Enhancer sequences located 3' of the mouse immunoglobulin lambda locus specify high-level expression of an immunoglobulin lambda gene in B cells of transgenic mice. Eccles S; Sarner N; Vidal M; Cox A; Grosveld F New Biol; 1990 Sep; 2(9):801-11. PubMed ID: 2126202 [TBL] [Abstract][Full Text] [Related]
13. Cells strongly expressing Ig(kappa) transgenes show clonal recruitment of hypermutation: a role for both MAR and the enhancers. Goyenechea B; Klix N; Yélamos J; Williams GT; Riddell A; Neuberger MS; Milstein C EMBO J; 1997 Jul; 16(13):3987-94. PubMed ID: 9233808 [TBL] [Abstract][Full Text] [Related]
14. The immunoglobulin heavy-chain locus hs3b and hs4 3' enhancers are dispensable for VDJ assembly and somatic hypermutation. Morvan CL; Pinaud E; Decourt C; Cuvillier A; Cogné M Blood; 2003 Aug; 102(4):1421-7. PubMed ID: 12714490 [TBL] [Abstract][Full Text] [Related]
15. Cutting edge: IFN-gamma regulated germline transcripts are expressed from gamma2a transgenes independently of the heavy chain 3' enhancers. Collins JT; Dunnick WA J Immunol; 1999 Dec; 163(11):5758-62. PubMed ID: 10570257 [TBL] [Abstract][Full Text] [Related]
16. B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Emu). Palomo C; Zou X; Nicholson IC; Bützler C; Brüggemann M Cancer Res; 1999 Nov; 59(21):5625-8. PubMed ID: 10554044 [TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin transgenes as targets for somatic hypermutation. Storb U; Peters A; Klotz E; Kim N; Shen HM; Hackett J; Rogerson B; O'Brien R; Martin TE Int J Dev Biol; 1998; 42(7):977-82. PubMed ID: 9853828 [TBL] [Abstract][Full Text] [Related]
18. Antibody repertoires of four- and five-feature translocus mice carrying human immunoglobulin heavy chain and kappa and lambda light chain yeast artificial chromosomes. Nicholson IC; Zou X; Popov AV; Cook GP; Corps EM; Humphries S; Ayling C; Goyenechea B; Xian J; Taussig MJ; Neuberger MS; Brüggemann M J Immunol; 1999 Dec; 163(12):6898-906. PubMed ID: 10586092 [TBL] [Abstract][Full Text] [Related]
19. Differential interactions between the immunoglobulin heavy chain mu intron and 3' enhancer. Mocikat R; Kardinal C; Klobeck HG Eur J Immunol; 1995 Nov; 25(11):3195-8. PubMed ID: 7489764 [TBL] [Abstract][Full Text] [Related]
20. Extensive junctional diversity in Ig light chain genes from early B cell progenitors of mu MT mice. Bentolila LA; Olson S; Marshall A; Rougeon F; Paige CJ; Doyen N; Wu GE J Immunol; 1999 Feb; 162(4):2123-8. PubMed ID: 9973486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]